Management Team

Dr. Amit Kumar, Ph.D
Dr. Amit Kumar, Ph.D Chairman, President & Chief Executive Officer

Dr. Kumar, the inventor of our Cchek™ technology, has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital ...

Read More

Michael Catelani
Michael Catelani Chief Operating Officer and Chief Financial Officer

Mike is a seasoned executive with over 25 years of experience in finance, auditing, and operations. Previously, Mike cofounded Tacere Therapeutics, Inc., a privately held biotech company, and served as its Chairman, President & Chief Financial Officer until its sale. Prior to Tacere, Mike served on the Board of Directors ...

Read More

John Roop
John Roop Senior Vice President of Engineering

Mr. Roop has over 20 years of experience as a Silicon Valley design engineer and engineering executive, and 20 years of experience in intellectual property.  Mr. Roop was a co-founder and Sr. Vice President of Engineering at StarSight Telecast, a pioneering developer of electronic program guides.  Mr. Roop was Vice ...

Read More

Anthony Campisi
Anthony Campisi Vice President of Engineering

Mr. Campisi has been responsible for Research & Development and Intellectual Property at Anixa for over 19 years. Prior to his employment with Anixa, Mr. Campisi was President of Cardinal Microsystems Corp. a company that designed and manufactured the video system for AT&T’s emergency 911 ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

Read More...

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

Read More...

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

Read More...

Cancer Fact: 27% of global cancer deaths occur in China.